Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 145,264 shares at $2.22 ($328K) on 2024-02-05, disclosed to the SEC on 2024-02-05.
Scheduled sale ($328k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.29 | 72,768 | $167K | 50.9% |
| 2 | $2.22 | 36,248 | $80K | 24.6% |
| 3 | $2.22 | 36,248 | $80K | 24.6% |
| Total | $2.26 avg | 145,264 | $328K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |